AR040234A1 - INHIBITING LINKS OF RAR RECEPTORS AND THEIR USE IN HUMAN MEDICINE AS WELL AS IN COSMETICS - Google Patents

INHIBITING LINKS OF RAR RECEPTORS AND THEIR USE IN HUMAN MEDICINE AS WELL AS IN COSMETICS

Info

Publication number
AR040234A1
AR040234A1 ARP030101952A ARP030101952A AR040234A1 AR 040234 A1 AR040234 A1 AR 040234A1 AR P030101952 A ARP030101952 A AR P030101952A AR P030101952 A ARP030101952 A AR P030101952A AR 040234 A1 AR040234 A1 AR 040234A1
Authority
AR
Argentina
Prior art keywords
radical
atom
linear
alkyl
branched
Prior art date
Application number
ARP030101952A
Other languages
Spanish (es)
Inventor
Thibaud Biadatti
Pascal Collette
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of AR040234A1 publication Critical patent/AR040234A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/28—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups having unsaturation outside the aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/17—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/19—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups having unsaturation outside the aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • C07C65/26—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/34—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups polycyclic
    • C07C65/36—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups polycyclic containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos biarílicos que responden a la fórmula general (1) así como su método de preparación, y su utilización en composiciones farmacéuticas destinadas a un uso en medicina humana o veterinaria, o también en composiciones cosméticas. Reivindicación 1: Compuestos caracterizados porque responden a la fórmula (1), en la cual: R1 representa un radical de fórmula (2) ó (3); R5 tiene las significaciones dadas a continuación; cada uno de R2 y R3, idénticos o diferentes, representan un átomo de H, un radical alquilo C1-6 lineales o ramificados, el radical -OR6, o el radical -NR7R8, o R2 y R3 tomados en forma conjunta, forman un ciclo de 6 eslabones eventualmente sustituidos por radicales alquilo C1-3 lineales o ramificados, R6, R7 y R8 tienen las significaciones dadas anteriormente; R4 representa un radical arilo o un radical heterociclo, X representa -CR9R10, un radical -C=O, o -C=N-OR11, R9, R10 y R11 tienen las significaciones dadas anteriormente; R5 representa un radical elegido entre las fórmulas (4) y (5); R12 y R13 tienen las significaciones dadas a continuación; R6 representa un átomo de H, un alquilo C1-6, o un radical bencilo eventualmente sustituido por un alquilo lineal o ramificado que tiene de 1 a 6 átomos de C, un halógeno, un radical dialquilamino o alcoxi, R7 y R8, idénticos o diferentes, representan un átomo de H, un radical alquilo que tiene de 1 a 6 átomos de C lineales o ramificados, o un radical bencilo, R9 representa un átomo de H, o un radical -OH; R10 y R11, idénticos o diferentes, representan un átomo de H o un radical alquilo lineal o ramificado que tiene de 1 a 6 átomos de C; R12 representa un grupo hidroxi, alcoxi, monoalquilamino, o dialquilamino; R13 representa un átomo de H, un radical hidroxi, o un radical amino; y los isómeros ópticos, las sales obtenidas con una sal o una base farmacéuticamente aceptable, así como las mezclas de dichos compuestos de fórmula (1).Biaryl compounds that respond to the general formula (1) as well as its method of preparation, and its use in pharmaceutical compositions intended for use in human or veterinary medicine, or also in cosmetic compositions. Claim 1: Compounds characterized in that they respond to formula (1), in which: R1 represents a radical of formula (2) or (3); R5 has the meanings given below; each of R2 and R3, identical or different, represent an H atom, a linear or branched C1-6 alkyl radical, the -OR6 radical, or the -NR7R8 radical, or R2 and R3 taken together, form a cycle of 6 links eventually substituted by linear or branched C1-3 alkyl radicals, R6, R7 and R8 have the meanings given above; R4 represents an aryl radical or a heterocycle radical, X represents -CR9R10, a radical -C = O, or -C = N-OR11, R9, R10 and R11 have the meanings given above; R5 represents a radical chosen between formulas (4) and (5); R12 and R13 have the meanings given below; R6 represents an H atom, a C1-6 alkyl, or a benzyl radical optionally substituted by a linear or branched alkyl having 1 to 6 C atoms, a halogen, a dialkylamino or alkoxy radical, R7 and R8, identical or different, they represent an H atom, an alkyl radical having 1 to 6 linear or branched C atoms, or a benzyl radical, R9 represents an H atom, or an -OH radical; R10 and R11, identical or different, represent an H atom or a linear or branched alkyl radical having 1 to 6 C atoms; R12 represents a hydroxy, alkoxy, monoalkylamino, or dialkylamino group; R13 represents an H atom, a hydroxy radical, or an amino radical; and optical isomers, salts obtained with a pharmaceutically acceptable salt or base, as well as mixtures of said compounds of formula (1).

ARP030101952A 2002-06-04 2003-06-02 INHIBITING LINKS OF RAR RECEPTORS AND THEIR USE IN HUMAN MEDICINE AS WELL AS IN COSMETICS AR040234A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0206850A FR2840299B1 (en) 2002-06-04 2002-06-04 NEW RAR RECEPTOR INHIBITOR LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS

Publications (1)

Publication Number Publication Date
AR040234A1 true AR040234A1 (en) 2005-03-23

Family

ID=29558950

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101952A AR040234A1 (en) 2002-06-04 2003-06-02 INHIBITING LINKS OF RAR RECEPTORS AND THEIR USE IN HUMAN MEDICINE AS WELL AS IN COSMETICS

Country Status (9)

Country Link
AR (1) AR040234A1 (en)
AT (1) ATE500866T1 (en)
CY (1) CY1111485T1 (en)
DE (1) DE60336312D1 (en)
DK (1) DK1513793T3 (en)
ES (1) ES2361303T3 (en)
FR (1) FR2840299B1 (en)
PT (1) PT1513793E (en)
SI (1) SI1513793T1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86387A1 (en) * 1986-04-04 1987-12-07 Oreal AROMATIC COMPOUNDS, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN AND VETERINARY MEDICINE AND IN COSMETICS
FR2764604B1 (en) * 1997-06-13 1999-09-10 Cird Galderma BI-AROMATIC COMPOUNDS LINKED BY A PROPYNYLENE OR ALLENYLENE RADICAL AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
DK1513793T3 (en) 2011-05-09
SI1513793T1 (en) 2011-06-30
DE60336312D1 (en) 2011-04-21
FR2840299B1 (en) 2006-05-05
FR2840299A1 (en) 2003-12-05
ATE500866T1 (en) 2011-03-15
ES2361303T3 (en) 2011-06-15
CY1111485T1 (en) 2015-08-05
PT1513793E (en) 2011-05-25

Similar Documents

Publication Publication Date Title
AR038326A1 (en) ANTIBACTERIALS PHENYLOXAZOLIDINONES REPLACED WITH BICYCLIC HETEROCICLICS AND RELATED COMPOSITIONS AND METHODS
AR063015A1 (en) DERIVATIVES OF QUINAZOLINONA 5-SUBSTITUTE AND COMPOSITIONS THAT INCLUDE THEM AND METHODS TO USE THEM IN THE TREATMENT OF CANCER
AR067779A1 (en) DIPEPTOID PROFARMS AND ITS USE
ECSP055853A (en) NEW DERIVATIVES OF HETEROCICLIC FLUOROGLYCOSIDS, PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS, AND THE USE OF THE SAME
CO5580765A2 (en) SPIROCICLIC CYCLHEXAN DERIVATIVES
AR049956A1 (en) DERIVATIVES OF 1,3 - OXAZOLIDIN - 2 - ONA AS CETP INHIBITORS AND LAD-C LEVEL ELEVATORS; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ATEROSCLEROSIS.
UY28859A1 (en) SELECTED CGRP ANTAGONISTS, PROCEDURE FOR PREPARATION AS WELL AS ITS USE AS A MEDICINAL PRODUCT
AR051735A1 (en) PIRROLIC INHIBITORS OF THE PROTEIN QUINASA ERK, SYNTHESIS AND INTERMEDIARIES OF THE SAME.
CO6251270A2 (en) NEW DERIVATIVES OF 6-TRIAZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL ITS PREPARATION PROCEDURE ITS APPLICATION AS MEDICINES PHARMACEUTICAL COMPOSITIONS AND NEW USE MAINLY AS MET INHIBITORS
AR057681A1 (en) INTERLEUQUINE-1 AND FACTOR-ALFA MODULATORS OF TUMOR NECROSIS; SYNTHESIS AND METHODS OF USE OF SUCH MODULATORS
AR063988A1 (en) HETEROCICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PE20050476A1 (en) PIRROL AND PIRAZOLE COMPOUNDS
AR058155A1 (en) PPARS MODULATING BIAROMATIC COMPOUNDS
CO6331467A2 (en) NEW IMIDAZO DERIVATIVES (1,2-A) PIRIDINA, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND NEW USE IN PARTICULARLY AS MET INHIBITORS
CY1116168T1 (en) TOY CCR3 HYPERCELLULATORS AND SALT SALTS
CO6331463A2 (en) NEW DERIVATIVES OF TRIAZOLO (4,3-A) PIRIDINA, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND NEW USE IN PARTICULARLY AS MET INHIBITORS
AR051796A1 (en) HYDANTOIN DERIVATIVES AS METALOPROTEINASE INHIBITORS
AR019190A1 (en) DERIVATIVES OF 2-AMINOPIRIDINES, INTERMEDIATE PRODUCTS FOR THEIR PREPARATION, DRUGS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE TO PREPARE DRUGS
DOP2011000019A (en) NEW IMIDAZO DERIVATIVES [1,2-A] PYRIMIDINE, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND NEW USE IN PARTICULARLY AS MET INHIBITORS
AR080249A1 (en) BRADIQUININA-B1 ANTAGONIST QUALITY COMPOUNDS
AR047486A1 (en) INDOLIZINE DERIVATIVES1,2,3,6,7,8, SUBSTITUTED, FGFS INHIBITORS, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR054678A1 (en) BI-AROMATIC COMPOUNDS ACTIVATORS OF PPAR TYPE RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS AND SUCH COMPOSITIONS
AR040234A1 (en) INHIBITING LINKS OF RAR RECEPTORS AND THEIR USE IN HUMAN MEDICINE AS WELL AS IN COSMETICS
AR052167A1 (en) PROCESS AND INTERMEDIARIES FOR THE PREPARATION OF CANPHOSPHAMIDE AND ITS SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING SOME INTERMEDIARIES, AND THEIR USE AS ANTICANCER AGENTS
CO6400223A2 (en) DERIVATIVES OF 6- (6-O-SUBSTITUTED-TRIAZOLOPIRIDAZINA-SULFANIL) BENZOTIAZOLES AND BENCIMIDAZOLS: PREPARATION, APPLICATION AS MEDICATIONS AND USE AS MET INHIBITORS

Legal Events

Date Code Title Description
FB Suspension of granting procedure